RESEARCH ON OUR SITE
 
 
MELUSYN
Industry & development Contents > Medicine > MELUSYN

Created in 2005, the Melusyn (Medicine and Synchrotron Light) Group is an independent French think tank whose mission is to assess the possibilities for development of medical activity in synchrotron light centers and to try to initiate their development. There are around fifty members: doctors, biologists, biochemists, biophysicists, and several industrial entities. In the statutory sense, Melusyn is a group housed within the ECRIN association (www.ecrin-asso.fr). The group is open to all interested individuals. It is currently subdivided into a “radiobiology” subgroup and a “cellular and tissue imagery” subgroup. The INSERM U647 team, a pioneering team that works closely with the medical personnel of the European synchrotron ESRF located in Grenoble, participates actively in the work of these two subgroups.

There is not yet any group equivalent to Melusyn in Europe; it falls, then, to Melusyn to play a federative role, especially with regard to structuring projects that are occurring in southern Paris around SOLEIL. 
The Melusyn group manager is Jean Doucet.
 
 
The Radiobiology group

This group includes representatives from most of the French teams in the field.  SOLEIL provides precious sources of “light” for radiobiology studies, thanks in particular to its very wide range of energy and ability to liberate harmonics.  This discipline is experiencing a renewal following the revelation that the effect of ionizing radiation does not depend solely on the dose.  It is necessary today to develop spatially and temporally resolved microdosimetry in order to clear the way for predictive radiobiology.  Melusyn may provide an opportunity to bring together teams in France working in this area.
  
The Radiobiology group manager is Yann Gauduel.

 

The Cellular and Tissue Imagery group

This group concerns itself with cellular and tissue imagery/spectroscopy for diagnostic purposes.  Its members come not only from CNRS, INSERM, university and C.E.A. laboratories, but also—and more importantly—from ten hospital units, mostly in France.  The involvement of hospital practitioners is essential to orient and guide reflection and to ensure the direct medical pertinence of projects.  These projects involve the development of molecular and morphological cell and biopsy imaging techniques that benefit from the brilliance, micrometric size, and chemical selectivity of synchrotron techniques. 
 
The Cellular and Tissue Imagery group manager is Jean Doucet.

 

Accueil